Mirae Asset Global Investments
BBIO icon

Mirae Asset Global Investments’s BridgeBio Pharma BBIO Stock Holding History

Mirae Asset Global Investments’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Sell
16,374
-1,273
-7% -$89.2K ﹤0.01% 860
2026
Q1 		$1.31M Buy
17,647
+7,813
+79% +$566K ﹤0.01% 808
2025
Q4 		$752K Buy
9,834
+2,443
+33% +$160K ﹤0.01% 941
2025
Q3 		$384K Buy
7,391
+56
+0.8% +$2.73K ﹤0.01% 1028
2025
Q2 		$317K Buy
7,335
+971
+15% +$35.3K ﹤0.01% 995
2025
Q1 		$223K Buy
6,364
+66
+1% +$2.23K ﹤0.01% 1030
2024
Q4 		$176K Sell
6,298
-503
-7% -$13K ﹤0.01% 1060
2024
Q3 		$170K Buy
6,801
+1,214
+22% +$31.9K ﹤0.01% 1115
2024
Q2 		$141K Sell
5,587
-56,157
-91% -$1.54M ﹤0.01% 1096
2024
Q1 		$1.16M Sell
61,744
-4,029
-6% -$137K ﹤0.01% 1452
2023
Q4 		$2.66M Buy
65,773
+904
+1% +$27.1K 0.01% 1132
2023
Q3 		$1.71M Sell
64,869
-3,481
-5% -$98.8K ﹤0.01% 1248
2023
Q2 		$1.17M Buy
68,350
+7,498
+12% +$113K ﹤0.01% 1473
2023
Q1 		$1.01M Buy
60,852
+13,426
+28% +$157K ﹤0.01% 1541
2022
Q4 		$361K Buy
47,426
+83
+0.2% +$795 ﹤0.01% 2055
2022
Q3 		$471K Buy
47,343
+13,363
+39% +$139K ﹤0.01% 1896
2022
Q2 		$308K Buy
+33,980
New +$284K ﹤0.01% 1975
2021
Q4 		– Sell
-6,085
Closed -$285K – 1585
2021
Q3 		$285K Buy
+6,085
New +$326K ﹤0.01% 1621

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Mirae Asset Global Investments's BBIO Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its BridgeBio Pharma (BBIO) stake by 7.2% in Q2 2026, selling an estimated $89.2K and leaving 16,374 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #860.

Mirae Asset Global Investments first reported a position in BBIO in Q3 2021 and has held it in 18 quarters since. The position peaked at $2.66M in Q4 2023. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Mirae Asset Global Investments held 16,374 shares of BridgeBio Pharma worth $1.22M as of Q2 2026.
  • Mirae Asset Global Investments sold 1,273 BridgeBio Pharma shares in Q2 2026, an estimated $89.2K.
  • BridgeBio Pharma made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #860 holding.
  • Mirae Asset Global Investments first reported a position in BridgeBio Pharma in Q3 2021 and has held it in 18 quarters since.
  • Mirae Asset Global Investments's BridgeBio Pharma position peaked at $2.66M in Q4 2023.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.